Technical Analysis for GSK - GlaxoSmithKline PLC

Grade Last Price % Change Price Change
grade F 36.18 -1.07% -0.39
GSK closed down 1.07 percent on Monday, October 19, 2020, on 1.14 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical GSK trend table...

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Slingshot Bearish Bearish Swing Setup -1.07%
Calm After Storm Range Contraction -1.07%
Narrow Range Bar Range Contraction -1.07%
Gapped Up Strength -1.07%
MACD Bearish Signal Line Cross Bearish 0.56%
Doji - Bullish? Reversal 0.56%
Below Lower BB Weakness 0.56%
Gapped Down Weakness 0.56%
Older End-of-Day Gignals for GSK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1% about 5 hours ago
Outside Day about 8 hours ago
Fell Below Lower Bollinger Band about 8 hours ago
Slingshot Bearish Entry about 8 hours ago
Fell Below Previous Day's Low about 8 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

GlaxoSmithKline plc, together with its subsidiaries, discovers, develops, manufactures, and markets pharmaceutical products, over-the-counter medicines, and health-related consumer products worldwide. It offers pharmaceutical products in various therapeutic areas comprising respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. The company provides prescription medicines to treat a range of conditions, including infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer. It also produces paediatric and adult vaccines to prevent a range of infectious diseases, including hepatitis A and B; diphtheria, tetanus, and whooping cough; measles, mumps, and rubella; polio; typhoid; influenza; and bacterial meningitis. In addition, it provides consumer health products in oral care, nutritional, total wellness, and skin health areas. The company's total wellness products include Panadol for the treatment of paracetamol-based treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; ENO Tums, a rapid relief antacid; and oral care products comprise Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to improve comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. Its nutrition products include Lucozade for energy and hydration; and Horlicks and Maxinutrition for nutrition; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. The company was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Energy Medicine Health Cancer Pharmaceutical Drugs Infectious Diseases Medication Pharmaceutical Products Rare Diseases Influenza Asthma HIV Nutrition Products Antibiotic Depression Infections Wellness Products Oral Care Products Eczema Fever Smoking Cessation Glaxosmithkline Nicotine Consumer Health Products Hepatitis A Joint Pain Measles Mumps Preventive Healthcare Rubella Tetanus

Is GSK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 48.25
52 Week Low 31.43
Average Volume 3,048,663
200-Day Moving Average 40.92
50-Day Moving Average 38.84
20-Day Moving Average 37.24
10-Day Moving Average 36.88
Average True Range 0.69
ADX 21.71
+DI 23.47
-DI 39.36
Chandelier Exit (Long, 3 ATRs ) 37.72
Chandelier Exit (Short, 3 ATRs ) 37.77
Upper Bollinger Band 38.33
Lower Bollinger Band 36.14
Percent B (%b) 0.02
BandWidth 5.88
MACD Line -0.65
MACD Signal Line -0.62
MACD Histogram -0.0257
Fundamentals Value
Market Cap 90.76 Billion
Num Shares 2.51 Billion
EPS 0.99
Price-to-Earnings (P/E) Ratio 36.47
Price-to-Sales 2.09
Price-to-Book 5.37
PEG Ratio 7.57
Dividend 1.89
Dividend Yield 5.22%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 37.22
Resistance 3 (R3) 37.30 37.03 37.04
Resistance 2 (R2) 37.03 36.77 36.99 36.98
Resistance 1 (R1) 36.61 36.61 36.48 36.53 36.93
Pivot Point 36.34 36.34 36.28 36.30 36.34
Support 1 (S1) 35.92 36.08 35.79 35.84 35.43
Support 2 (S2) 35.65 35.92 35.61 35.38
Support 3 (S3) 35.23 35.65 35.32
Support 4 (S4) 35.15